Can-Fite BioPharma Ltd. Retained Earnings
Can-Fite BioPharma Ltd. (CANF) had Retained Earnings of -$176.19 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-03-26
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$176.19M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$171.24M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$166.36M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$162.44M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$176.19M 20-F · filed 2026-03-26 |
| 2025-06-30 | -$171.24M 6-K · filed 2025-08-28 |
| 2024-12-31 | -$166.36M 20-F · filed 2026-03-26 |
| 2024-06-30 | -$162.44M 6-K · filed 2024-08-29 |
| 2023-12-31 | -$158.48M 20-F · filed 2025-04-14 |
| 2023-06-30 | -$155.07M 6-K · filed 2023-08-31 |
| 2022-12-31 | -$150.85M 20-F · filed 2024-03-28 |
| 2022-06-30 | -$145.30M 6-K · filed 2022-08-25 |
| 2021-12-31 | -$140.67M 20-F · filed 2023-03-30 |
| 2021-06-30 | -$130.57M 6-K · filed 2021-08-26 |
| 2020-12-31 | -$125.47M 20-F · filed 2022-03-24 |
| 2020-06-30 | -$119.26M 6-K · filed 2020-08-27 |
| 2019-12-31 | -$110.31M 20-F · filed 2021-03-25 |
| 2018-12-31 | -$97.69M 6-K · filed 2020-06-01 |